NYKODE THERAPEUTICS ASA (NYKD.OL) Stock Analyst Earnings Estimates
OSL:NYKD - Euronext Oslo - NO0010714785 - Common Stock - Currency: NOK
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.168M -78.89% | 12.902M 79.99% | 8.679M -32.73% | 4.59M | 1.7M -62.96% | -100.00% | 4.284M | 705.78M 16,374.79% | 2.537B 259.46% | 5.998B 136.42% | |
| EBITDA YoY % growth | -48.85M -598.76% | -54.237M -11.03% | -44.88M 17.25% | -29.478M | -23.426M 20.53% | -28.764M -22.79% | -179.904M -525.45% | -596.779M -231.72% | 942.33M 257.90% | 2.647B 180.90% | |
| EBIT YoY % growth | -50.664M -555.84% | -56.359M -11.24% | -47.131M 16.37% | -35.649M | -29.708M 16.67% | -27.489M 7.47% | -269.856M -881.69% | -668.349M -147.67% | -35.235M 94.73% | 2.555B 7,351.41% | |
| Operating Margin | -706.81% | -436.82% | -543.05% | -776.67% | -1,747.50% | N/A | -6,299.15% | -94.70% | -1.39% | 42.60% | |
| EPS YoY % growth | N/A -1,364.33% | -1.26 -744.06% | -0.12 90.47% | -0.10 | -0.08 17.24% | -0.10 -25.00% | -1.07 -949.90% | -1.54 -43.91% | -0.11 92.86% | 3.78 3,536.70% |
Reported data in USD, estimates in NOK
| Q2 / 25 | Q3 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.02 | -0.02 |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | -5.202M | -5.202M |
| EBIT Q2Q % growth | -5.814M | -5.916M |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.02 90.74% | -0.03 | 0.01 | 34.64% |
| Q3 2024 Q2Q % growth | -0.03 90.45% | -0.04 | 0.01 | 32.12% |
| Q2 2024 Q2Q % growth | -0.02 93.75% | -0.06 | 0.04 | 68.68% |
| Q1 2024 Q2Q % growth | -0.05 87.75% | -0.05 | 0.00 | 2.04% |
| Q4 2023 Q2Q % growth | -0.22 46.80% | -0.54 | 0.33 | 60.17% |
| Q3 2023 Q2Q % growth | -0.31 | -0.58 | 0.26 | 45.76% |
| Q2 2023 Q2Q % growth | -0.32 | -0.53 | 0.21 | 39.23% |
| Q1 2023 Q2Q % growth | -0.41 | -0.53 | 0.12 | 22.57% |
| Q4 2022 Q2Q % growth | -0.41 | -0.41 | 0.00 | 0.04% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are NOK.
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 6.894M -70.90% | 1.462M | 5.432M | 371.55% |
| Q3 2024 Q2Q % growth | 536K -98.15% | 3.162M | -2.626M | -83.05% |
| Q2 2024 Q2Q % growth | 544K -98.98% | 3.11M | -2.566M | -82.51% |
| Q1 2024 Q2Q % growth | 827.04K -97.41% | 68.84M | -68.013M | -98.80% |
| Q4 2023 Q2Q % growth | 23.689M 780.63% | 22.219M | 1.47M | 6.62% |
| Q3 2023 Q2Q % growth | 28.921M 4,363.12% | 22.01M | 6.911M | 31.40% |
| Q2 2023 Q2Q % growth | 53.505M 1,618.21% | 10.564M | 42.941M | 406.48% |
| Q1 2023 Q2Q % growth | 31.987M 4,373.71% | 10.564M | 21.423M | 202.79% |
| Q4 2022 Q2Q % growth | 2.69M -91.30% | 10.346M | -7.656M | -74.00% |
| Q3 2022 Q2Q % growth | 648K -35.26% | % | ||
| Q2 2022 Q2Q % growth | 3.114M 93.66% | % | ||
| Q1 2022 Q2Q % growth | 715K 60.31% | % | ||
| Q4 2021 Q2Q % growth | 30.908M -85.62% | % | ||
| Q4 2020 Q2Q % growth | 215M 467,491.30% | % | ||
| Q3 2020 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |